SmithKline

GSK is a leading global biopharmaceutical company headquartered in London, dedicated to uniting science, technology, and talent to get ahead of disease together. The company focuses on four main therapeutic areas: infectious diseases, HIV, oncology, and immunology/respiratory. GSK is a world leader in vaccines, boasting a diverse portfolio that includes major products like Shingrix for shingles and Arexvy for respiratory syncytial virus. Following the 2022 demerger of its consumer healthcare business, Haleon, GSK has transitioned into a pure-play biopharma entity with a sharpened focus on R&D innovation. The company leverages advanced technologies such as functional genomics, artificial intelligence, and various vaccine platforms to develop its pipeline of over 70 programs. GSK's commitment to global health is reflected in its significant presence in both developed and emerging markets.